FI963277A0 - Paramuunisuusinduktori, joka perustuu rokkoviruskomponenttien yhdistelmiin, menetelmä sen valmistamiseksi ja sen käyttö lääkeaineena - Google Patents

Paramuunisuusinduktori, joka perustuu rokkoviruskomponenttien yhdistelmiin, menetelmä sen valmistamiseksi ja sen käyttö lääkeaineena

Info

Publication number
FI963277A0
FI963277A0 FI963277A FI963277A FI963277A0 FI 963277 A0 FI963277 A0 FI 963277A0 FI 963277 A FI963277 A FI 963277A FI 963277 A FI963277 A FI 963277A FI 963277 A0 FI963277 A0 FI 963277A0
Authority
FI
Finland
Prior art keywords
combinations
parauneal
drug
preparation
poxvirus components
Prior art date
Application number
FI963277A
Other languages
English (en)
Swedish (sv)
Other versions
FI963277A (fi
FI116557B (fi
Inventor
Anton Mayr
Original Assignee
Anton Mayr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anton Mayr filed Critical Anton Mayr
Publication of FI963277A publication Critical patent/FI963277A/fi
Publication of FI963277A0 publication Critical patent/FI963277A0/fi
Application granted granted Critical
Publication of FI116557B publication Critical patent/FI116557B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI963277A 1994-02-23 1996-08-22 Paramuunisuusinduktori, joka perustuu rokkoviruskomponenttien yhdistelmiin, menetelmä sen valmistamiseksi ja sen käyttö lääkeaineena FI116557B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4405841 1994-02-23
DE4405841A DE4405841C1 (de) 1994-02-23 1994-02-23 Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP9500160 1995-01-17
PCT/EP1995/000160 WO1995022978A1 (en) 1994-02-23 1995-01-17 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament

Publications (3)

Publication Number Publication Date
FI963277A FI963277A (fi) 1996-08-22
FI963277A0 true FI963277A0 (fi) 1996-08-22
FI116557B FI116557B (fi) 2005-12-30

Family

ID=6511005

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963277A FI116557B (fi) 1994-02-23 1996-08-22 Paramuunisuusinduktori, joka perustuu rokkoviruskomponenttien yhdistelmiin, menetelmä sen valmistamiseksi ja sen käyttö lääkeaineena

Country Status (20)

Country Link
US (1) US6805870B1 (fi)
EP (1) EP0669133B1 (fi)
JP (1) JP2873880B2 (fi)
KR (1) KR100196204B1 (fi)
CN (1) CN1142187A (fi)
AT (1) ATE153242T1 (fi)
AU (1) AU690625B2 (fi)
BR (1) BR9506882A (fi)
CA (1) CA2182207C (fi)
DE (2) DE4405841C1 (fi)
DK (1) DK0669133T3 (fi)
ES (1) ES2102081T3 (fi)
FI (1) FI116557B (fi)
GR (1) GR3023508T3 (fi)
HU (1) HU220972B1 (fi)
NO (1) NO319250B1 (fi)
NZ (1) NZ278079A (fi)
PL (1) PL182132B1 (fi)
SI (1) SI0669133T1 (fi)
WO (1) WO1995022978A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2247336C (en) * 1996-02-28 2008-06-17 Bayer Aktiengesellschaft Parapoxviruses containing foreign dna, their production and their use in vaccines
KR100302994B1 (ko) * 1996-04-15 2001-11-30 안톤 마이어 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용
JPH1192390A (ja) * 1997-09-17 1999-04-06 Natl Fedelation Of Agricult Coop Assoc ストレス状態改善剤
WO2000000216A2 (en) * 1998-06-26 2000-01-06 Aventis Pasteur Use of poxviruses as enhancer of specific immunity
DE19922407A1 (de) * 1999-05-14 2000-11-16 Bayer Ag Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus
US6682742B1 (en) * 1999-05-28 2004-01-27 Gsf Forschungszentrum Fur Unwelt Und Gesundheit Gmbh Vector for integration of heterologous sequences into poxviral genomes
CN1291012C (zh) * 2000-03-14 2006-12-20 巴法里安诺迪克有限公司 修饰的安卡拉牛痘病毒(mva)的变株
DE10122233A1 (de) * 2000-07-11 2002-01-24 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
DE10122451A1 (de) * 2000-07-11 2002-04-04 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis zur Herstellung von antiviralen Arzneimitteln und Arzneimitteln gegen Krebs
CN1452496B (zh) * 2000-07-11 2012-10-10 艾库里斯有限及两合公司 绵羊副痘病毒毒株抗器官纤维化的用途
RU2003104525A (ru) * 2000-07-11 2004-06-27 Байер Акциенгезельшафт (De) Применение штаммов вируса parapox ovis для получения антивирусных и противораковых лекарственных средств
CZ295808B6 (cs) 2000-11-23 2005-11-16 Bavarian Nordic A/S Modifikovaný virus vakcinie typu Ankara
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
US7628980B2 (en) * 2000-11-23 2009-12-08 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
US7097842B2 (en) * 2000-11-23 2006-08-29 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
UA82466C2 (uk) * 2001-07-18 2008-04-25 Бавариан Нордика А/С Спосіб посилення ампліфікації хордопоксвірусу
CA2466413C (en) 2001-12-04 2014-11-04 Bavarian Nordic A/S Flavivirus ns1 subunit vaccine
US6723329B2 (en) * 2001-12-07 2004-04-20 Board Of Regents, The University Of Texas System Use of parapox B2L protein to modify immune responses to administered antigens
US6752995B2 (en) * 2002-04-15 2004-06-22 Board Of Regents, The University Of Texas System Nucleic acid and polypeptide sequences useful as adjuvants
AU2002362072A1 (en) * 2001-12-07 2003-06-23 Board Of Regents The University Of Texas System Use a parapox b2l protein to modify immune responses to administered antigens
MXPA04010353A (es) * 2002-04-19 2005-03-07 Bavarian Nordic As Virus de la vaccina modificada ankara para la vacunacion de neonatos.
EA009008B1 (ru) * 2002-09-05 2007-10-26 Бавариан Нордик А/С Способ амплификации вируса оспы
DE102004003572A1 (de) 2004-01-23 2005-08-18 Bavarian Nordic A/S Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens
CN1984666A (zh) * 2004-07-13 2007-06-20 爱库里斯股份有限两合公司 与其他抗病毒剂联合治疗hiv/aids的副痘病毒
DE102004046391A1 (de) * 2004-09-24 2006-04-06 Bioveta Ag Neuer Impfstoff für veterinäre und humanmedizinische Prophylaxe und Therapie
DE102005027956B4 (de) * 2005-06-16 2009-10-22 Mayr, Anton, Prof. Dr. Dr. h.c. mult. Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen
US20140255447A1 (en) * 2013-03-05 2014-09-11 Biomune Company Production of avian embryo cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3816139A1 (de) * 1987-10-17 1989-04-27 Bayer Ag Verfahren zur herstellung von paramunitaetsinducern

Also Published As

Publication number Publication date
PL182132B1 (pl) 2001-11-30
CA2182207C (en) 2000-02-29
PL316024A1 (en) 1996-12-23
EP0669133B1 (de) 1997-05-21
WO1995022978A1 (en) 1995-08-31
ES2102081T3 (es) 1997-07-16
NO319250B1 (no) 2005-07-04
CA2182207A1 (en) 1995-08-31
ATE153242T1 (de) 1997-06-15
DE59402826D1 (de) 1997-06-26
CN1142187A (zh) 1997-02-05
AU1416795A (en) 1995-09-11
KR970701062A (ko) 1997-03-17
HUT75545A (en) 1997-05-28
EP0669133A1 (de) 1995-08-30
NZ278079A (en) 1998-01-26
FI963277A (fi) 1996-08-22
US6805870B1 (en) 2004-10-19
BR9506882A (pt) 1997-08-19
JP2873880B2 (ja) 1999-03-24
DE4405841C1 (de) 1995-01-05
NO963462L (no) 1996-08-20
KR100196204B1 (ko) 1999-06-15
HU9601947D0 (en) 1996-09-30
GR3023508T3 (en) 1997-08-29
SI0669133T1 (en) 1997-10-31
JPH09504803A (ja) 1997-05-13
DK0669133T3 (da) 1997-07-14
AU690625B2 (en) 1998-04-30
FI116557B (fi) 2005-12-30
HU220972B1 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
FI963277A (fi) Paramuunisuusinduktori, joka perustuu rokkoviruskomponenttien yhdistelmiin, menetelmä sen valmistamiseksi ja sen käyttö lääkeaineena
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
EA199800946A1 (ru) Концентрированный препарат антител
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
FI964681A (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
TR199802651T2 (xx) Piridilalken, Piridil-Alkin Asit Amidleri
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
ITRM910922A0 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e metodo per applicarla.
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
IT8821134A0 (it) Frazioni oligomeriche procianidoliche, loro procedimentodi preparazione e composizioni farmaceutiche che le contengono.
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
DE69808130D1 (de) Adamantan-derivate
TR200002299T2 (tr) Epotilon kompozisyonları.
SE9704546D0 (sv) Novel compounds
DE69834923D1 (en) Hochgradig lipophile camptothecin-derivate
FI865060A (fi) Polymeeridispersioita, menetelmä niiden valmistamiseksi sekä niiden käyttö sideaineena
EE03663B1 (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
ES2140489T3 (es) Receptor de interferona soluble, su preparacion y su uso.
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
GT199900062A (es) Preparados efervescentes.
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
DE3788888D1 (de) Perhydrothiazepin- und Perhydroazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116557

Country of ref document: FI

MM Patent lapsed